Samir Patel

Samir is an engineer with an entrepreneurial spirit. Previously, Samir was a co-founder and leader of Clearside Biomedical (NASDAQ: CLSD). Clearside is an ophthalmic pharmaceutical company developing targeted therapies for ocular diseases. He invented the suprachoroidal drug delivery technology that lead to the creation of Clearside Biomedical and its first FDA approved therapy. Samir obtained a dual B.S. degree in Chemical and Material Science Engineering from University of California at Berkeley and has a doctoral degree in Chemical Engineering from the Georgia Institute of Technology. Between degrees Samir worked at ALZA Corp, a J&J subsidiary.